Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data-Reference-Cited by-同舟云学术

Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data

Published:2021-01-01 Issue:1 Volume:24 Page:665-674
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Yang Jingyan¹²^ORCID,Liu Rongzhe³^ORCID,Granghaud Anna⁴,Zaidi Omer⁵^ORCID,Stephens Jennifer³^ORCID

Affiliation:

1. Patient Health and Impact (PHI), Pfizer Inc, New York, NY, USA

2. Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USA

3. Pharmerit – an OPEN Health Company, Bethesda, MD, USA

4. Pfizer SAS, Paris, France

5. Pharmerit – an OPEN Health Company, Boston, MA, USA

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1922252

Reference48 articles.

1. Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

2. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

3. Chemotherapy dose reduction and delay in clinical practice

4. Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positional Isoform Analysis of Pegylated Biotherapeutic Protein Using a Novel Peptide-Based Reversed-Phase Chromatography Approach;2024

2. Emerging themes and factors influencing the prices of biotherapeutics;World Medical & Health Policy;2023-05-02

3. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products;Journal of Controlled Release;2022-11

4. An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review;Ophthalmology and Therapy;2022-03-12

5. Purification of Modified Therapeutic Proteins Available on the Market: An Analysis of Chromatography-Based Strategies;Frontiers in Bioengineering and Biotechnology;2021-08-20